Merger Between PE, Third Wave Collapses Because of Slow Approval Process

Jun 07, 2000

Premium

MADISON, Wis.--PE Biosystems and privately-held Third Wave Technologies have agreed to terminate their merger agreement that was announced in January because the US government approval was taking too long. Both companies will continue to collaborate.

PE was going to buy Third Wave for 1.972 million shares of PE Biosystems Group stock in a deal valued at $330 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Truth Seekers

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Quick Cell Edits

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

This Week in Science

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Genes for Success

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Featured White Papers

Best Practices for RNA Transcriptome Sequencing

Tissue Section Imaging

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Jul

24

Featured Webinar

Identifying Inherited Risk Factors of Pancreatic Cancer Using Targeted Sequencing in a Large Cohort

In this webinar, Dr. Fergus Couch from the Mayo Clinic will present data from a large study that used a targeted sequencing panel to determine pancreatic cancer risk associated with inherited mutations in several cancer predisposition genes.

Aug

07

Featured Webinar

Rapid and Comprehensive NGS Variant Interpretation Using Web-Based Software

This webinar will present the results of an evaluation of a web-based variant interpretation software system for clinical next-generation sequencing.

Aug

20

Featured Webinar

GenomeWeb/ABRF 2018 Webinar Series: Advances in Single-Cell RNA-Seq: Novel Technologies, Practical Applications

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.

Aug

27

Featured Webinar

Case Study: Genetic Testing Lab Sees 25-Fold Scaleup with New Informatics System

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Main menu